Image-based analysis of lipid nanoparticle–mediated siRNA delivery, intracellular trafficking and endosomal escape (original) (raw)

• Vaishnaw, A.K. et al. A status report on RNAi therapeutics. Silence 1, 14 (2010).
  Article Google Scholar
• Czech, B. & Hannon, G.J. Small RNA sorting: matchmaking for Argonautes. Nat. Rev. Genet. 12, 19–31 (2011).
  Article CAS Google Scholar
• Sliva, K. & Schnierle, B.S. Selective gene silencing by viral delivery of short hairpin RNA. Virol. J. 7, 248 (2010).
  Article Google Scholar
• Shim, M.S. & Kwon, Y.J. Efficient and targeted delivery of siRNA in vivo. FEBS J. 277, 4814–4827 (2010).
  Article CAS Google Scholar
• Zhang, S., Zhao, Y., Zhi, D. & Zhang, S. Non-viral vectors for the mediation of RNAi. Bioorg. Chem. 40, 10–18 (2012).
  Article Google Scholar
• Semple, S.C. et al. Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 28, 172–176 (2010).
  Article CAS Google Scholar
• Jayaraman, M. et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew. Chem. Int. Edn Engl. 51, 8529–8533 (2012).
  Article CAS Google Scholar
• Frank-Kamenetsky, M. et al. Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc. Natl. Acad. Sci. USA 105, 11915–11920 (2008).
  Article CAS Google Scholar
• Love, K.T. et al. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl. Acad. Sci. USA 107, 1864–1869 (2010).
  Article CAS Google Scholar
• Akinc, A. et al. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotechnol. 26, 561–569 (2008).
  Article CAS Google Scholar
• Zeigerer, A. et al. Rab5 is necessary for the biogenesis of the endolysosomal system in vivo. Nature 485, 465–470 (2012).
  Article CAS Google Scholar
• Trial to Evaluate Safety and Tolerability of ALN-PCS02 in Subjects With Elevated LDL-Cholesterol (LDL-C). NCT01437059 (Registry of Federally and Privately Supported Clinical Trials, U.S. National Institutes of Health, 2011.
• Trial to Evaluate Safety, Tolerability, and Parmacokinetics of ALN-TTR02 in Healthy Volunteer Subjects. NCT01559077 (Registry of Federally and Privately Supported Clinical Trials, US National Institutes of Health, 2012.
• Akinc, A. et al. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol. Ther. 18, 1357–1364 (2010).
  Article CAS Google Scholar
• Basha, G. et al. Influence of cationic lipid composition on gene silencing properties of lipid nanoparticle formulations of siRNA in antigen-presenting cells. Mol. Ther. 19, 2186–2200 (2011).
  Article CAS Google Scholar
• Tamura, A., Oishi, M. & Nagasaki, Y. Enhanced cytoplasmic delivery of siRNA using a stabilized polyion complex based on PEGylated nanogels with a cross-linked polyamine structure. Biomacromolecules 10, 1818–1827 (2009).
  Article CAS Google Scholar
• Akita, H. et al. Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: programmed endosomal escape and dissociation. J. Control. Release 143, 311–317 (2010).
  Article CAS Google Scholar
• Sakurai, Y. et al. Endosomal escape and the knockdown efficiency of liposomal-siRNA by the fusogenic peptide shGALA. Biomaterials 32, 5733–5742 (2011).
  Article CAS Google Scholar
• Bramsen, J.B. et al. A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity. Nucleic Acids Res. 37, 2867–2881 (2009).
  Article CAS Google Scholar
• Macia, E. et al. Dynasore, a cell-permeable inhibitor of dynamin. Dev. Cell 10, 839–850 (2006).
  Article CAS Google Scholar
• Doherty, G.J. & McMahon, H.T. Mechanisms of endocytosis. Annu. Rev. Biochem. 78, 857–902 (2009).
  Article CAS Google Scholar
• Schnatwinkel, C. et al. The Rab5 effector Rabankyrin-5 regulates and coordinates different endocytic mechanisms. PLoS Biol. 2, e261 (2004).
  Article Google Scholar
• Meier, O. et al. Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J. Cell Biol. 158, 1119–1131 (2002).
  Article CAS Google Scholar
• Schmees, C. et al. Macropinocytosis of the PDGF beta-receptor promotes fibroblast transformation by H-RasG12V. Mol. Biol. Cell 23, 2571–2582 (2012).
  Article CAS Google Scholar
• Gruenberg, J. & Maxfield, F.R. Membrane transport in the endocytic pathway. Curr. Opin. Cell Biol. 7, 552–563 (1995).
  Article CAS Google Scholar
• Dominska, M. & Dykxhoorn, D.M. Breaking down the barriers: siRNA delivery and endosome escape. J. Cell Sci. 123, 1183–1189 (2010).
  Article CAS Google Scholar
• Pei, Y. et al. Quantitative evaluation of siRNA delivery in vivo. RNA 16, 2553–2563 (2010).
  Article CAS Google Scholar
• Maier, M. in 8th Annual Meeting of the Oligonucleotide Therapeutics Society, Boston. (2012).
• Wei, J. et al. RNA-induced silencing complex-bound small interfering RNA is a determinant of RNA interference-mediated gene silencing in mice. Mol. Pharmacol. 79, 953–963 (2011).
  Article CAS Google Scholar
• Romberg, B., Hennink, W.E. & Storm, G. Sheddable coatings for long-circulating nanoparticles. Pharm. Res. 25, 55–71 (2008).
  Article CAS Google Scholar
• Wheeler, J.J. et al. Stabilized plasmid-lipid particles: construction and characterization. Gene Ther. 6, 271–281 (1999).
  Article CAS Google Scholar
• Tomas, M.I., Kucic, N., Mahmutefendic, H., Blagojevic, G. & Lucin, P. Murine cytomegalovirus perturbs endosomal trafficking of major histocompatibility complex class I molecules in the early phase of infection. J. Virol. 84, 11101–11112 (2010).
  Article CAS Google Scholar
• Rink, J., Ghigo, E., Kalaidzidis, Y. & Zerial, M. Rab conversion as a mechanism of progression from early to late endosomes. Cell 122, 735–749 (2005).
  Article CAS Google Scholar
• Poteryaev, D., Datta, S., Ackema, K., Zerial, M. & Spang, A. Identification of the switch in early-to-late endosome transition. Cell 141, 497–508 (2010).
  Article CAS Google Scholar
• Landesman, Y. et al. In vivo quantification of formulated and chemically modified small interfering RNA by heating-in-Triton quantitative reverse transcription polymerase chain reaction (HIT qRT-PCR). Silence 1, 16 (2010).
  Article Google Scholar
• Lee, S.H., Choi, S.H., Kim, S.H. & Park, T.G. Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock. J. Control. Release 125, 25–32 (2008).
  Article CAS Google Scholar
• Hafez, I.M., Maurer, N. & Cullis, P.R. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther. 8, 1188–1196 (2001).
  Article CAS Google Scholar
• Lewis, J. et al. In vivo silencing of alpha-synuclein using naked siRNA. Mol. Neurodegener. 3, 19 (2008).
  Article Google Scholar
• Hauser, P.V. et al. Novel siRNA delivery system to target podocytes in vivo. PLoS ONE 5, e9463 (2010).
  Article Google Scholar
• Xia, C.F., Boado, R.J. & Pardridge, W.M. Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology. Mol. Pharm. 6, 747–751 (2009).
  Article CAS Google Scholar
• Valiunas, V. et al. Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions. J. Physiol. (Lond.) 568, 459–468 (2005).
  Article CAS Google Scholar
• Wolfrum, C. et al. Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nat. Biotechnol. 25, 1149–1157 (2007).
  Article CAS Google Scholar
• Ohya, T. et al. Reconstitution of Rab- and SNARE-dependent membrane fusion by synthetic endosomes. Nature 459, 1091–1097 (2009).
  Article CAS Google Scholar
• Starai, V.J., Jun, Y. & Wickner, W. Excess vacuolar SNAREs drive lysis and Rab bypass fusion. Proc. Natl. Acad. Sci. USA 104, 13551–13558 (2007).
  Article CAS Google Scholar
• Andaloussi, S.E. et al. Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo. Nucleic Acids Res. 39, 3972–3987 (2011).
  Article Google Scholar
• Bartz, R. et al. Effective siRNA delivery and target mRNA degradation using an amphipathic peptide to facilitate pH-dependent endosomal escape. Biochem. J. 435, 475–487 (2011).
  Article CAS Google Scholar
• Kobayashi, T. et al. The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. Mol. Biol. Cell 11, 1829–1843 (2000).
  Article CAS Google Scholar
• Damha, M.J. & Ogilvie, K.K. Oligoribonucleotide synthesis. The silyl-phosphoramidite method. Methods Mol. Biol. 20, 81–114 (1993).
  CAS PubMed Google Scholar
• Soutschek, J. et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432, 173–178 (2004).
  Article CAS Google Scholar
• Addepalli, H. et al. Modulation of thermal stability can enhance the potency of siRNA. Nucleic Acids Res. 38, 7320–7331 (2010).
  Article CAS Google Scholar
• Manoharan, M., Kesavan, V. & Rajeev, K.G. Modified iRNA agents. US Patent 7,745,608 (2010).